What Real Science in Women’s Health Looks Like

What Real Science in Women’s Health Looks Like

Author: by FemmeHealth Alliance August 21, 2025 Duration: 25:15

Half the population experiences these conditions. Many are universal, recurring, and clinically significant. Yet in the eyes of too many investors, women’s health therapeutics remain “optional.”

In this episode of Blindspot Capital, I sit down with Sabrina Johnson, President & CEO of Daré Bioscience, to unpack the misconceptions holding back investment in women’s health from contraception to menopause to vaginal health and explore how disciplined science can change the game.

In This Episode We Cover:

🟣 Why women’s health markets are larger and more recurrent than most investors realize

🟣 The false perception that women’s health conditions are “lifestyle” or “optional”

🟣 The reality of recruiting participants for women’s health trials (and why stigma isn’t a barrier)

🟣 What scientific credibility really looks like in biotech and how to protect it

🟣 The difference between medicine and marketing and why the distinction matters for investors

🟣 Why angel investors have a leadership opportunity in women’s health

Join 10,000+ readers of the FemmeHealth newsletter on Substack.

------------------------------

Why You Should Listen If you care about women’s health, biotech, or the intersection of science and capital, this is a clear-eyed look at the market opportunities hiding in plain sight and the leadership it will take to unlock them.

About Sabrina Johnson Sabrina Johnson is the President & CEO of Daré Bioscience, a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority. Daré believes that innovation does not have to start from scratch.

The company’s goal is to bring to market as soon as practicable innovative evidence-based solutions that address decades of unmet needs in women’s health and enhance outcomes and convenience, primarily in the areas of contraception, sexual health, pelvic pain, fertility, infectious disease, vaginal health and menopause. Learn more Here

🎧 Listen now and share with someone who still thinks women’s health is “niche.”

📌 Watch on YouTube



Get full access to The Billion Dollar Blindspot at blog.billiondollarblindspot.com/subscribe

There's a vast, often overlooked frontier in business and innovation, and Blindspot Capital is mapping its terrain. This podcast digs into the ideas, trends, and tangible investment potential shaping the future of women's health, a sector that has historically been underfunded and underserved. Each episode moves beyond surface-level discussions to examine the systemic gaps and the consequential opportunities they create. You'll hear from founders, investors, researchers, and thinkers who are actively building and funding solutions in this space, sharing their on-the-ground experiences and hard-won insights. The conversations are grounded in the reality of entrepreneurship and market dynamics, exploring not just the "why" but the "how"-how new technologies are being applied, how businesses are scaling, and how capital can be deployed to generate both impact and returns. Tune in for a clear-eyed look at an area ripe for transformation, where understanding the blind spot isn't just about awareness, but about seeing a path forward for savvy builders and backers alike. This isn't a niche side conversation; it's a central dialogue about the next wave of growth in healthcare and technology, delivered through a podcast dedicated to substantive, forward-thinking analysis.
Author: Language: English Episodes: 18

Blindspot Capital
Podcast Episodes
Blind Spot Capital is Here! [not-audio_url] [/not-audio_url]

Duration: 1:14
Blind Spot Capital Podcast TrailerWelcome to Blind Spot Capital, the podcast where health innovation meets investment insight. Every year, investors bet billions on the future of health but most still miss one of the big…
Episode #5: Transforming PostPartum Care with AI [not-audio_url] [/not-audio_url]

Duration: 52:08
In this conversation, Maryann and Astrid Gyllenkrok, CEO and Co-Founder of LEIA Health discuss the challenges of parenthood, particularly focusing on the postpartum experience and the need for better support systems for…
Episode #4: Breaking Barriers in Drug Delivery for Women [not-audio_url] [/not-audio_url]

Duration: 31:14
In this episode of FemmeHealth Founders, Maryann speaks with Dr. Lara Zibners, co-founder of Calla Lily Clinical Care, about the inadequacies in current drug delivery methods for women's health. Lara shares her personal…
Episode #3 - The Story Behind OvulaRing [not-audio_url] [/not-audio_url]

Duration: 40:25
In this episode of Notes to Selfe, we dive into the fascinating world of women's health innovation with Sebastian Alexander, founder and CEO of VivoSensMedical. We explore the journey of OvulaRing, a groundbreaking techn…
Femme Health Founders Episode #1 [not-audio_url] [/not-audio_url]

Duration: 29:43
Hormones rule our lives—from puberty to menopause, they influence everything from our mood to our health. But why do some women experience severe side effects while others don’t?In this episode of the FemmeHealth Founder…